Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Depreciation & Amortization (2016 - 2017)

Tenax Therapeutics' Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $573025.0 for Q3 2017.

  • For Q3 2017, Accumulated Depreciation & Amortization fell 5.19% year-over-year to $573025.0; the TTM value through Sep 2017 reached $573025.0, down 5.19%, while the annual FY2016 figure was $567625.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2017 was $573025.0 at Tenax Therapeutics, roughly flat from $575081.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $999003.0 in Q1 2013 and bottomed at $567625.0 in Q4 2016.
  • The 4-year median for Accumulated Depreciation & Amortization is $589738.0 (2016), against an average of $674713.1.
  • The largest annual shift saw Accumulated Depreciation & Amortization fell 24.18% in 2016 before it fell 5.19% in 2017.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $999003.0 in 2013, then dropped by 25.06% to $748604.0 in 2015, then dropped by 24.18% to $567625.0 in 2016, then grew by 0.95% to $573025.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Accumulated Depreciation & Amortization are $573025.0 (Q3 2017), $575081.0 (Q2 2017), and $571657.0 (Q1 2017).